Sat, Dec 27, 2014, 9:49 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

DexCom, Inc. (DXCM) Message Board

  • tmcg1367 tmcg1367 Feb 25, 2012 12:08 PM Flag

    Jeffries boosts target 40%

    Previous posters have done a good job on keeping this board informed. I am surprised that Yahoo Finance hasn't posted more stories on these analyst comments. If you notice at the end of the article, this analyst increased the estimated loss for FY 12. Since he raised the price target so dramatically, he must believe the extra expense is worthwhile.

    Streetinsider.com article about Jeffries price target increase:

    Jefferies boosted its price target DexCom (NASDAQ: DXCM) from $10 to $14 and reiterated its Buy rating following Q4 results.

    The firm comments, "DXCM preannounced 4Q results of $22.4mn, reflecting a strong seasonal uptick in sensor utilization. 2012 is shaping up to be a year of investment as the company sets the stage for the Gen4 sensor launch."

    FY12 EPS was trimmed from ($0.57) to ($0.72).

    http://www.streetinsider.com/Analyst+Comments/Jefferies+Raises+Price+Target+on+DexCom+%28DXCM%29+40%25+After+Q4+Results/7211414.html

 
DXCM
55.15+0.21(+0.38%)Dec 26 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Prothena Corporation plc
NASDAQFri, Dec 26, 2014 4:00 PM EST
TherapeuticsMD, Inc.
AMEXFri, Dec 26, 2014 4:01 PM EST